Exact Sciences Files for $125M Stock Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences said after the close of the market Wednesday that it has launched a $125 million public offering of common stock.

The Madison, Wis.-based molecular diagnostics developer didn't say how many shares it intends to offer.

Its stock closed at $14.25 in Wednesday trade on the Nasdaq but was down around 5 percent at $13.49 Thursday morning.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.